This indefinite delivery contract (IDC) SPE2DH22D0002 was awarded by the Defense Logistics Agency (DLA) to Luminex Corporation, a manufacturer of biological testing technologies, to provide various medical products and services to support the agency's Medical Supply Chain program.
The contract, valued at $48,125,000, has a period of performance through November 4, 2026 and does not utilize any set-aside designations. Luminex, a foreign-owned, for-profit organization, often serves as a prime contractor delivering specialized multiplex diagnostic solutions, assay kits, reagents, and related products to government customers including the Centers for Disease Control and Prevention, Department of Veterans Affairs, and Department of Defense. The task orders issued under this IDC include the supply of Xtag Cystic Fibrosis Kits, Magplex microspheres, Aries C. Difficile Assays, and Luminex 100/200 performance verification services at firm fixed prices. These products and services support clinical testing programs and biomedical research efforts across federal agencies.
Generated 1/1/25, 9:04 AM